DermatologicS&K Therapeutics discloses new FGFR1 activatorsS&K Therapeutics Co. Ltd. has discovered peptides acting as fibroblast growth factor receptor 1 (FGFR1) activators reported to be useful for the treatment of skin lesions, diabetic wounds, and tissue repair and regeneration.